The unified social credit code/registration number of Zibo Wanjie Pharmaceutical Co., Ltd. is 9 1370304688264935A, and the enterprise legal person is Gao Maiqing. At present, the enterprise is in the state of opening.
The business scope of Zibo Wanjie Pharmaceutical Co., Ltd. is: production and sales of tablets, hard capsules (all containing antineoplastic drugs) and raw materials (deoxyuridine, fludarabine phosphate, capecitabine and pemetrexed disodium); Lease of houses, sites and equipment (projects subject to approval according to law can only be operated after approval by relevant departments). In Shandong province, the total registered capital of companies with similar business scope is 2114.36 million yuan, and the main capital is concentrated in 30 enterprises with a scale of more than 50 million. In the province, the registered capital of enterprises is good at present.
Zibo Wanjie Pharmaceutical Co., Ltd. invested in 0 companies, 1 branch.
See more information and materials of Zibo Wanjie Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.